Related Parties and Related Party Transactions (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Jan. 31, 2023 |
|
| Prepaid Expenses | $ 333 | $ 333 | $ 2,601 | ||
| Accounts Payable And Accrued Expenses | 1,634 | 1,634 | 1,072 | ||
| Stock Based Compensation | 1,792 | $ 1,915 | |||
| FMV [Member] | |||||
| Prepaid Expenses | 0 | 0 | 2,000 | ||
| Accounts Payable And Accrued Expenses | 130 | 130 | 28 | ||
| Loans Payable | 957 | 957 | $ 13 | ||
| Consulting Expenses | 66 | $ 30 | 198 | 90 | |
| Payroll expenses | 120 | 132 | 358 | 484 | |
| Stock Based Compensation | $ 631 | $ 575 | $ 1,931 | $ 1,725 | |
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|